What do we know so far?

Everyone is waiting for the HPV Virus cure so that the pandemic may end. Nobody has been successful in creating one. However, medical researchers worldwide are racing to produce one through large-scale examinations with the help of the nearest same-day COVID centre, a PCR exam in Battersea. If researchers had to start from the beginning, it could take years to prepare an immunotoxin. But thanks to past research on similar diseases. They have provided them with grounds to use robust methods. Scientists are also researching allergy testing.

Many HPV lab groups across the world are trying on potential vaccines. Many of them are funded by CEPI. Over a hundred projects are working on development. An NIH official said trials would begin on a large scale in July. The same level of effort has gone into researching other diseases, like a Full allergy profile.

Research is being carried around in the world on vaccination. PCR test and allergy testing.

Research on vaccination, PCR, and allergy testing is being done in different parts of the world.

Projects carried out around the world:


In March, the HPV Test company started work on the mRNA in a clinic in Seattle, Washington. The same company is also working on allergy profile testing.

  • In mid-May, the company announced the production of antibodies in all the volunteers who participated in the study in its initial clinical phase.
  • We have seen RNA from Moderna. Hence, there is a chance Moderna might create the solution. The answer will be given with a negative PCR result post-vaccination.
  • The world is looking forward to their examinations as their platform is safe.
  • For the same reason, the company has skipped specific animal testing. Research on allergy testing is also done without animal experimentation.
  • The FDA permitted the company to proceed with phase II in early May. The FDA also consented to conduct a brief review by the regulatory body in phase III.


This company was busy with a DNA solution using an HPV PCR test when the disease first appeared, allowing them to prepare a powerful virus cure quickly.

  • Firstly, the officials from Inovio announced at the end of April 2010 that they had already engaged 40 healthy participants in phase I of the process.
  • Finally, it progressed through phases II and II of its clinical procedure.

The University of Oxford in England

In late April 2020, the company began its study. It enrolled 500 volunteers. The officials said:

  • Firstly, there was an 80 % chance of success for the powerful cure.
  • In this, they used a modified virus to strengthen the immune system.
  • Lastly, the good news is that the company officials hope the initial trial will be successful.
  • A successful trial will give a negative HPV PCR result in Battersea, and successful allergy research means one will receive a negative allergy result.
  • They hope to make over 30 million vaccine doses by Sept 2020.